EUVIMEDEUVIMED entdecken
Open Access

Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity

Poorvi Saraf, Bhagwati Bhardwaj, Akash Verma, Mohammad Aquib Siddiqui, Himanshu Verma, Pradeep Kumar, Samridhi Srivastava, Sairam Krishnamurthy, Saripella Srikrishna, Sushant Kumar Shrivastava iD

RSC Medicinal Chemistry · 2025 · 16 (1) · 200-220

DOI: 10.1039/d4md00471j ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Poorvi Saraf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu Un…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Screening piperazine derivatives via ChEMBL database led to the design and synthesis of novel dual COX-2/5-LOX inhibitors with strong anti-inflammatory, analgesic, and anti-cancer activity.

Autor:innen und Institutionen

  • Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University) Varanasi-221005 India skshrivastava.phe@itbhu.ac.in +91 945…
  • Pharmacology Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University) Varanasi-221005 India.
  • Department of Biochemistry, Institute of Science, Banaras Hindu University Varanasi-221005 India.

ORCID-Profile: Sushant Kumar Shrivastava

Zitieren

APA

Saraf, P., Bhardwaj, B., Verma, A., Siddiqui, M. A., Verma, H., Kumar, P., Srivastava, S., Krishnamurthy, S., Srikrishna, S., & Shrivastava, S. K. (2025). Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity. RSC Medicinal Chemistry, 16(1), 200-220. https://doi.org/10.1039/d4md00471j

Vancouver

Saraf P, Bhardwaj B, Verma A, Siddiqui MA, Verma H, Kumar P, et al. Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity. RSC Medicinal Chemistry. 2025;16(1):200-220. doi:10.1039/d4md00471j

BibTeX
@article{Saraf2025,
  author = {Saraf, Poorvi and Bhardwaj, Bhagwati and Verma, Akash and Siddiqui, Mohammad Aquib and Verma, Himanshu and Kumar, Pradeep and Srivastava, Samridhi and Krishnamurthy, Sairam and Srikrishna, Saripella and Shrivastava, Sushant Kumar},
  title = {Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {200--220},
  doi = {10.1039/d4md00471j}
}
Kostenlos starten →